Company Cizzle Biotechnology Holdings Plc
Equities
PSL
GB00BNG2VN02
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.65 GBX | 0.00% | -1.49% | -15.38% |
04-30 | EARNINGS: Avacta sales jump; Poolbeg loss narrows; Digital 9 NAV down | AN |
04-30 | Cizzle Biotechnology Holdings Plc Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 4
Managers
Managers | Title | Age | Since |
---|---|---|---|
Nigel Lee
DFI | Director of Finance/CFO | 63 | 13/05/21 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Dawn Coverley
BRD | Director/Board Member | 59 | 13/05/21 |
Nigel Lee
DFI | Director of Finance/CFO | 63 | 13/05/21 |
John Treacy
BRD | Director/Board Member | 42 | 28/01/19 |
Allan Syms
CHM | Chairman | 67 | 20/05/19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 396,391,773 | 237,343,096 ( 59.88 %) | 0 | 59.88 % |
Company contact information
Cizzle Biotechnology Holdings Plc
60 Gracechurch Street 6th Floor
EC3V 0HR, London
+44 20 7469 0930
http://www.cizzlebiotechnology.comSector
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-15.38% | 8.36M | |
+55.70% | 55.7B | |
+41.08% | 39.91B | |
-5.39% | 39.57B | |
-5.56% | 28.16B | |
+16.46% | 26.3B | |
-20.56% | 18.94B | |
+33.03% | 12.17B | |
+25.85% | 12.12B | |
+2.72% | 12.12B |
- Stock Market
- Equities
- PSL Stock
- Company Cizzle Biotechnology Holdings Plc